Effect of storage on levels of nitric oxide metabolites in platelet preparations

Transfusion

Volumn 53, Issue 3, 2013, Pages 637-644

  Park, Ji Won ^b   Piknova, Barbora ^b   Kurtz, James ^b   Seetharaman, Shalini ^b   Wagner, Stephen J ^b   Schechter, Alan N ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b HOLLAND LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITRITE; POLITEF;

ARTICLE; CELL SEPARATION; CONTAINER; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; ERYTHROCYTE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LEUKAPHERESIS; LEUKOCYTE; NORMAL HUMAN; PLASMA; SUPERNATANT; THROMBOCYTE PRESERVATION; THROMBOCYTOPHERESIS;

BLOOD PLATELETS; BLOOD PRESERVATION; DRUG CONTAMINATION; DRUG PACKAGING; HUMANS; NITRATES; NITRIC OXIDE; NITRITES; PLATELETPHERESIS; POLYTETRAFLUOROETHYLENE; TIME FACTORS;

EID: 84874945688     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03777.x     Document Type: Article

References (52)

1. Ignarro LJ, Byrns RE, Buga GM, Wood KS,. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 1987; 61: 866-79.
2. Palmer RM, Ferrige AG, Moncada S,. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-6.
3. Palmer RM, Ashton DS, Moncada S,. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-6.
4. Azuma H, Ishikawa M, Sekizaki S,. Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol 1986; 88: 411-5.
5. Gkaliagkousi E, Ferro A,. Nitric oxide signalling in the regulation of cardiovascular and platelet function. Front Biosci 2011; 16: 1873-97.
6. Antl M, von Bruhl ML, Eiglsperger C, Werner M, Konrad I, Kocher T, Wilm M, Hofmann F, Massberg S, Schlossmann J,. IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation. Blood 2007; 109: 552-9.
7. Cavallini L, Coassin M, Borean A, Alexandre A,. Prostacyclin and sodium nitroprusside inhibit the activity of the platelet inositol 1,4,5-trisphosphate receptor and promote its phosphorylation. J Biol Chem 1996; 271: 5545-51.
8. Trepakova ES, Cohen RA, Bolotina VM,. Nitric oxide inhibits capacitative cation influx in human platelets by promoting sarcoplasmic/endoplasmic reticulum Ca2+-ATPase-dependent refilling of Ca2+ stores. Circ Res 1999; 84: 201-9.
9. Hauser W, Knobeloch KP, Eigenthaler M, Gambaryan S, Krenn V, Geiger J, Glazova M, Rohde E, Horak I, Walter U, Zimmer M,. Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilator-stimulated phosphoprotein knockout mice. Proc Natl Acad Sci U S A 1999; 96: 8120-5.
10. Roberts W, Michno A, Aburima A, Naseem KM,. Nitric oxide inhibits von Willebrand factor-mediated platelet adhesion and spreading through regulation of integrin alpha(IIb)beta(3) and myosin light chain. J Thromb Haemost 2009; 7: 2106-15.
11. de Graaf JC, Banga JD, Moncada S, Palmer RM, de Groot PG, Sixma JJ,. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 1992; 85: 2284-90.
12. Radomski MW, Palmer RM, Moncada S,. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci U S A 1990; 87: 5193-7.
13. Ozuyaman B, Godecke A, Kusters S, Kirchhoff E, Scharf RE, Schrader J,. Endothelial nitric oxide synthase plays a minor role in inhibition of arterial thrombus formation. Thromb Haemost 2005; 93: 1161-7.
14. Gambaryan S, Kobsar A, Hartmann S, Birschmann I, Kuhlencordt PJ, Muller-Esterl W, Lohmann SM, Walter U,. NO-synthase-/NO-independent regulation of human and murine platelet soluble guanylyl cyclase activity. J Thromb Haemost 2008; 6: 1376-84.
15. Tymvios C, Moore C, Jones S, Solomon A, Sanz-Rosa D, Emerson M,. Platelet aggregation responses are critically regulated in vivo by endogenous nitric oxide but not by endothelial nitric oxide synthase. Br J Pharmacol 2009; 158: 1735-42.
16. Weitzberg E, Lundberg JO,. Nonenzymatic nitric oxide production in humans. Nitric Oxide 1998; 2: 1-7.
17. Zweier JL, Samouilov A, Kuppusamy P,. Non-enzymatic nitric oxide synthesis in biological systems. Biochim Biophys Acta 1999; 1411: 250-62.
18. Gladwin MT, Schechter AN, Kim-Shapiro DB, Patel RP, Hogg N, Shiva S, Cannon RO 3rd, Kelm M, Wink DA, Espey MG, Oldfield EH, Pluta RM, Freeman BA, Lancaster JR Jr, Feelisch M, Lundberg JO,. The emerging biology of the nitrite anion. Nat Chem Biol 2005; 1: 308-14.
19. Lundberg JO, Weitzberg E, Gladwin MT,. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 2008; 7: 156-67.
20. Duncan C, Dougall H, Johnston P, Green S, Brogan R, Leifert C, Smith L, Golden M, Benjamin N,. Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate. Nat Med 1995; 1: 546-51.
21. Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, Yang BK, Waclawiw MA, Zalos G, Xu X, Huang KT, Shields H, Kim-Shapiro DB, Schechter AN, Cannon RO 3rd, Gladwin MT,. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 2003; 9: 1498-505.
22. Nagababu E, Ramasamy S, Abernethy DR, Rifkind JM,. Active nitric oxide produced in the red cell under hypoxic conditions by deoxyhemoglobin-mediated nitrite reduction. J Biol Chem 2003; 278: 46349-56.
23. Shiva S, Huang Z, Grubina R, Sun J, Ringwood LA, MacArthur PH, Xu X, Murphy E, Darley-Usmar VM, Gladwin MT,. Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ Res 2007; 100: 654-61.
24. Rassaf T, Flogel U, Drexhage C, Hendgen-Cotta U, Kelm M, Schrader J,. Nitrite reductase function of deoxymyoglobin: oxygen sensor and regulator of cardiac energetics and function. Circ Res 2007; 100: 1749-54.
25. Zhang Z, Naughton DP, Blake DR, Benjamin N, Stevens CR, Winyard PG, Symons MC, Harrison R,. Human xanthine oxidase converts nitrite ions into nitric oxide (NO). Biochem Soc Trans 1997; 25: 524S.
26. Millar TM, Stevens CR, Benjamin N, Eisenthal R, Harrison R, Blake DR,. Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Lett 1998; 427: 225-8.
27. Godber BL, Doel JJ, Sapkota GP, Blake DR, Stevens CR, Eisenthal R, Harrison R,. Reduction of nitrite to nitric oxide catalyzed by xanthine oxidoreductase. J Biol Chem 2000; 275: 7757-63.
28. Carlsson S, Wiklund NP, Engstrand L, Weitzberg E, Lundberg JO,. Effects of pH, nitrite, and ascorbic acid on nonenzymatic nitric oxide generation and bacterial growth in urine. Nitric Oxide 2001; 5: 580-6.
29. Webb AJ, Patel N, Loukogeorgakis S, Okorie M, Aboud Z, Misra S, Rashid R, Miall P, Deanfield J, Benjamin N, MacAllister R, Hobbs AJ, Ahluwalia A,. Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension 2008; 51: 784-90.
30. Srihirun S, Sriwantana T, Unchern S, Kittikool D, Noulsri E, Pattanapanyasat K, Fucharoen S, Piknova B, Schechter AN, Sibmooh N,. Platelet inhibition by nitrite is dependent on erythrocytes and deoxygenation. PLoS ONE 2012; 7: e30380.
31. Seghatchian J, Krailadsiri P,. The platelet storage lesion. Transfus Med Rev 1997; 11: 130-44.
32. Holme S,. Storage and quality assessment of platelets. Vox Sang 1998; 74 (Suppl 2): 207-16.
33. Holme S, Moroff G, Murphy S,. A multi-laboratory evaluation of in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock. Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion. Transfusion 1998; 38: 31-40.
34. Perrotta PL, Perrotta CL, Snyder EL,. Apoptotic activity in stored human platelets. Transfusion 2003; 43: 526-35.
35. Ohto H, Nollet KE,. Overview on platelet preservation: better controls over storage lesion. Transfus Apher Sci 2011; 44: 321-5.
36. Klinger MH,. The storage lesion of platelets: ultrastructural and functional aspects. Ann Hematol 1996; 73: 103-12.
37. Yang BK, Vivas EX, Reiter CD, Gladwin MT,. Methodologies for the sensitive and specific measurement of S-nitrosothiols, iron-nitrosyls, and nitrite in biological samples. Free Radic Res 2003; 37: 1-10.
38. Basu S, Wang X, Gladwin MT, Kim-Shapiro DB,. Chemiluminescent detection of S-nitrosated proteins: comparison of tri-iodide, copper/CO/cysteine, and modified copper/cysteine methods. Methods Enzymol 2008; 440: 137-56.
39. Joseph J, Kalyanaraman B, Hyde JS,. Trapping of nitric oxide by nitronyl nitroxides: an electron spin resonance investigation. Biochem Biophys Res Commun 1993; 192: 926-34.
40. Hogg N, Singh RJ, Joseph J, Neese F, Kalyanaraman B,. Reactions of nitric oxide with nitronyl nitroxides and oxygen: prediction of nitrite and nitrate formation by kinetic simulation. Free Radic Res 1995; 22: 47-56.
41. Mellion BT, Ignarro LJ, Ohlstein EH, Pontecorvo EG, Hyman AL, Kadowitz PJ,. Evidence for the inhibitory role of guanosine 3′, 5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 1981; 57: 946-55.
42. Schafer AI, Alexander RW, Handin RI,. Inhibition of platelet function by organic nitrate vasodilators. Blood 1980; 55: 649-54.
43. Radomski MW, Palmer RM, Moncada S,. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 1987; 92: 181-7.
44. Lundberg JO, Weitzberg E,. The biological role of nitrate and nitrite: the times they are a-changin'. Nitric Oxide 2010; 22: 61-3.
45. Govoni M, Jansson EA, Weitzberg E, Lundberg JO,. The increase in plasma nitrite after a dietary nitrate load is markedly attenuated by an antibacterial mouthwash. Nitric Oxide 2008; 19: 333-7.
46. Lundberg JO, Weitzberg E,. NO generation from inorganic nitrate and nitrite: role in physiology, nutrition and therapeutics. Arch Pharm Res 2009; 32: 1119-26.
47. Carmen R,. The selection of plastic materials for blood bags. Transfus Med Rev 1993; 7: 1-10.
48. Murphy S,. Platelet storage for transfusion. Semin Hematol 1985; 22: 165-77.
49. Mowery KA, Schoenfisch MH, Saavedra JE, Keefer LK, Meyerhoff ME,. Preparation and characterization of hydrophobic polymeric films that are thromboresistant via nitric oxide release. Biomaterials 2000; 21: 9-21.
50. Bicak N, Sherrington DC, Bulbul H,. Vinylamine polymer via chemical modification of PVC. Eur Polym J 2001; 37: 801-5.
51. Zhang H, Annich GM, Miskulin J, Osterholzer K, Merz SI, Bartlett RH, Meyerhoff ME,. Nitric oxide releasing silicone rubbers with improved blood compatibility: preparation, characterization, and in vivo evaluation. Biomaterials 2002; 23: 1485-94.
52. Arora S, Tyagi YK, Kumar A, Majumder S, Saluja D, Raj HG, Chatterjee S, Saso L, Prasad AK, Parmar VS,. The role of calreticulin transacetylase in the activation of human platelet nitrite reductase by polyphenolic acetates. Biol Pharm Bull 2009; 32: 161-5.